Kathryn Romano - Chief Accounting Officer at Krystal Biotech, Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

Past-year transaction volume for Kathryn Romano in Krystal Biotech, Inc.

Buys

Open market
Shares
Avg price
Total value

Sells

Open market
Shares
-13,250
Avg price
$271.88
Total value
-$3,602,405

Net

Past year
Shares
-13,250
Share %
-100%
Total value
-$3,602,405

Reported holdings for Kathryn Romano in Krystal Biotech, Inc.

Form 4 holding Chief Accounting Officer

Krystal Biotech, Inc.

Security class
Performance Stock Units
Shares / value
0
Estimated value
$1,322,925
Report date
27 Feb 2026
Price
$176.39
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Accounting Officer

Krystal Biotech, Inc.

Security class
Restricted Stock Units
Shares / value
5,442
Estimated value
$388,058
Report date
27 Feb 2026
Price
$176.39
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Accounting Officer

Krystal Biotech, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
13,575
Estimated value
Report date
27 Feb 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Kathryn Romano in Krystal Biotech, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .